P

Inventor

EDELMAN JEFFREY L

US22 patents
⚠️ This page may combine multiple inventors who share the name “EDELMAN JEFFREY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALLERGAN INC

17 patents
US7771742B2Aug 10, 2010

Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods

ALLERGAN INC47 citations97
US8968766B2Mar 3, 2015

Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods

ALLERGAN INC19 citations91
US10076492B2Sep 18, 2018

Biodegradable intravitreal tyrosine kinase implants

ALLERGAN INC4 citations84
US9233070B2Jan 12, 2016

Biodegradable intravitreal tyrosine kinase implants

ALLERGAN INC6 citations84
US9433631B2Sep 6, 2016

4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC3 citations83
US8906892B2Dec 9, 2014

4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC5 citations83
US9259429B2Feb 16, 2016

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

ALLERGAN INC3 citations82
US8865691B2Oct 21, 2014

Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC4 citations82
US10881608B2Jan 5, 2021

Biodegradable intravitreal tyrosine kinase implants

ALLERGAN INC1 citations73
US10188665B2Jan 29, 2019

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

ALLERGAN INC1 citations71
US7749530B2Jul 6, 2010

Kinase inhibitors

ALLERGAN INC5 citations62
US9717743B2Aug 1, 2017

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC1 citations61
US9820995B2Nov 21, 2017

Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues

ALLERGAN INC1 citations60
US8383825B2Feb 26, 2013

Kinase inhibitors

ALLERGAN INC0 citations52
US10493082B2Dec 3, 2019

4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC0 citations51
US10188667B2Jan 29, 2019

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

ALLERGAN INC0 citations51
US8969583B2Mar 3, 2015

3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors

ALLERGAN INC0 citations38

EDELMAN JEFFREY L

3 patents

SPADA LON T

2 patents